Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

vaccine - Trending on BuzzSumo 2023-11-26

Summary:

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa businesswire.com

Link:

https://www.businesswire.com/news/home/20231126169373/en/Vaxxas-Announces-and-Publishes-Successful-Phase-I-Clinical-Trial-for-Measles-and-Rubella-Vaccine-Delivered-Using-its-Proprietary-High-Density-Microarray-Skin-Patch-Plan-for-Phase-III-Trial-in-The-Gambia-Africa

From feeds:

Tags:

all_vaccine

Date tagged:

11/26/2023, 22:55

Date published:

11/26/2023, 17:01